BioCryst Pharmaceuticals, Inc. (BCRX)

14.92
0.21 1.40
NASDAQ
Prev Close 15.13
Open 15.10
Day Low/High 14.91 / 15.24
52 Wk Low/High 3.46 / 18.48
Volume 3.06M
Exchange NASDAQ
Shares Outstanding 178.87B
Market Cap 2.76B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Inflationary Concerns, Banks Report Earnings, Netflix Soars: Market Recon

Inflationary Concerns, Banks Report Earnings, Netflix Soars: Market Recon

I did warn publicly back in another epoch that quantitative easing would lead toward increased consumer level inflation.

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

Horizon Shares Rise on Q3 Results, Guidance -- Biotech Movers

The Dublin firm on Nov. 6 unveiled third-quarter numbers that topped analysts' estimates and raised its full-year net sales outlook and the lower end of its 2017 adjusted Ebitda guidance.

Wait for the Pullback on BioCryst Pharmaceuticals

Wait for the Pullback on BioCryst Pharmaceuticals

Prices are extended so don't go long just yet.

Everything We Know About BioCryst's New HAE Drug

Everything We Know About BioCryst's New HAE Drug

BioCryst's Hereditary angioedema drug-trial results not compelling.

Big-Cap Tech Names, Biotechs, Oils Lifting Market

Big-Cap Tech Names, Biotechs, Oils Lifting Market

The number of new 12-month highs has climbed to 240.

Finally Getting Back to a Stock Picker's Market

Finally Getting Back to a Stock Picker's Market

The euphoria has calmed down, and if stocks can consolidate, we will have some better entry points.

Shark Bites: What, Market Worry?

Shark Bites: What, Market Worry?

Talk about Dow 20,000 is probably feeding off itself.

Valeant Stock Plunge Puts Focus on Chairman

Robert Ingram sits on four public company boards and is a director at three private companies, which governance experts view as cause for concern.

Midday Report: Chesapeake Energy Tanks; Stocks Extend Selloff

Midday Report: Chesapeake Energy Tanks; Stocks Extend Selloff

U.S. stocks picked up where they left off last week, extending a sharp selloff on Monday on worries over oil and disappointing earnings.

Biocryst upgraded at BofA/Merrill

A Decent First Step

A Decent First Step

Does today's bounce means this little correction is ending?

Buy or Get Out of the Way

Buy or Get Out of the Way

Market players are adding long exposure as the market runs away from them.